Topics

Collaboration aimed at improving the accuracy of data analysis for chromatin immunoprecipitation (ChIP) sequencing experiments.

These highly prescribed medications change cell surface protein expression, which is particularly problematic in cells in the respiratory system—tissue that is vulnerable to targeting and attack by the COVID-19 virus.

The Axiom Precision Medicine Research Array is a powerful genotyping solution with more than 900,000 markers

Companies' tumor profiling assays will identify abnormalities qualifying a patient for personalized cancer treatment through NCI-MATCH.

While a patient may unknowingly skirt unseen dangers, like a latter-day Magoo blindly wandering past open manholes, physicians would rather patients be aware of...

Artificial intelligence (AI) is gaining a foothold in the discovery and development of drugs and diagnostics—but its use in both will remain limited unless companies surmount hurdles to the technology in the next few years, a panel of industry executives agreed.

Company accused of submitting false claims to Medicare for the Decipher prostate cancer test between September 2015 and June 2017

Non-invasive diagnostics maker CareDx, which focuses on early detection of organ rejection in kidney and heart transplant patients, announced its blood-based test AlloSure has...

Telomere length hasn’t been a reliable yardstick for measuring the progress of cancer. Because cancer cells divide frequently, and because telomeres shorten with repeated...

Researchers headed by teams at the Chinese Academy of Sciences, and Massachusetts Institute of Technology (MIT), have used CRISPR-Cas9 gene editing to engineer macaque...